Alkermes PLC (ALKS) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 9, 2026.

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free
Filings shown
11
Open-market buys
0
Open-market sells
9

Counts cover the 11 most recent Form 4 filings Tradune holds for ALKS (filed Jul 6 – Oct 9, 2026); the score below covers only the trailing 90 days (0 buys, 8 sells). No completed check of ALKS's Form 4 list on SEC EDGAR is on record yet; the latest ALKS filing Tradune holds was filed Oct 9, 2026. This is not guaranteed to be the complete record — see ALKS's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 10 filings Tradune holds for ALKS filed Aug 3 – Oct 9, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

8 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
7 sales· 31,678 sh
checkbox disclosed
On filings with the box not checked
1 sale· 44,472 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
David Joseph GaffinEVP, CLO, Alkermes, Inc. 0 3 — 6,102 −$279,919
Craig C. HopkinsonEVP R&D, Chief Medical Officer 0 2 — 18,000 −$860,094
Christian Todd NicholsSVP, Chief Commercial Officer 0 2 — 7,576 −$372,937
nancy lynn Md snydermanDirector 0 1 — 44,472 −$2,239,076

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score
0/ 100
Net insider sales
0 distinct buyers0 buy · 8 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at ALKS

No open-market insider purchases (Form 4 code P) were reported for ALKS between Jul 6, 2026 and Oct 9, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Joshua Reed SVP, Chief Financial Officer · filed Oct 9, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Restricted Stock Unit Award 9,164 — — — Oct 8, 2026
Tax withholding 4,069 $40.11 5,095 −44% Oct 8, 2026
Option exercise 9,164 — 9,164 — Oct 8, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

Anne Clem Whitaker Director · filed Oct 9, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Non Qualified Stock Option (Right to Buy) 17,998 — — — Oct 7, 2026
Grant / award Restricted Stock Unit Award 7,239 — — — Oct 7, 2026
David Joseph Gaffin EVP, CLO, Alkermes, Inc. · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 2,034 $41.03 221,388 −0.9% Oct 2, 2026

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

David Joseph Gaffin EVP, CLO, Alkermes, Inc. · filed Sep 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 2,034 $48.01 223,422 −0.9% Sep 3, 2026
Craig C. Hopkinson EVP R&D, Chief Medical Officer · filed Sep 1, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 5,000 $24.59 74,389 +7.2% Sep 1, 2026
Open-market sale 10b5-1 box checked 9,000 $46.99 65,389 −12% Sep 1, 2026
Option exercise Employee Stock Option (Right to Buy) 5,000 — — — Sep 1, 2026
Christian Todd Nichols SVP, Chief Commercial Officer · filed Aug 17, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 664 $49.65 102,193 −0.6% Aug 17, 2026
Open-market sale 10b5-1 box checked 6,912 $49.19 102,857 −6.3% Aug 17, 2026
Blair Curtis Jackson President & CEO, Alkermes plc · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Employee Stock Option (Right to Buy) 124,305 — — — Aug 5, 2026
Grant / award Employee Stock Option (Right to Buy) 93,229 — — — Aug 5, 2026
nancy lynn Md snyderman Director · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 27,948 $46.72 43,343 +182% Aug 3, 2026
Option exercise Non Qualified Stock Option (Right to Buy) 16,524 — — — Aug 3, 2026
Option exercise Non Qualified Stock Option (Right to Buy) 27,948 — — — Aug 3, 2026
Open-market sale 10b5-1 box not checked 44,472 $50.35 15,395 −74% Aug 3, 2026
Option exercise 16,524 $46.72 59,867 +38% Aug 3, 2026
Craig C. Hopkinson EVP R&D, Chief Medical Officer · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 104 $19.34 73,493 +0.1% Aug 3, 2026
Open-market sale 10b5-1 box checked 9,000 $48.58 69,389 −11% Aug 3, 2026
Option exercise Employee Stock Option (Right to Buy) 104 — — — Aug 3, 2026
Option exercise Employee Stock Option (Right to Buy) 4,896 — — — Aug 3, 2026
Option exercise 4,896 $24.59 78,389 +6.7% Aug 3, 2026
David Joseph Gaffin EVP, CLO, Alkermes, Inc. · filed Aug 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 2,034 $48.58 225,456 −0.9% Aug 3, 2026
David Joseph Gaffin EVP, CLO, Alkermes, Inc. · filed Jul 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 2,034 $54.03 227,490 −0.9% Jul 6, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to ALKS's (Oct 9, 2026).

Frequently asked about ALKS insider activity

How many insiders bought ALKS stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of ALKS shares were reported by Alkermes PLC insiders between Jul 6, 2026 and Oct 9, 2026. The 11 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for ALKS?

The most recent Form 4 on this page was filed by Anne Clem Whitaker (Director) on Oct 9, 2026, reporting 2 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market ALKS insider sale shown?

The largest open-market sale among the filings shown was 44,472 ALKS shares at $50.35 (about $2,239,076) by nancy lynn Md snyderman (Director) on Aug 3, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for ALKS — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

Track ALKS insider filings free →

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.